References
- Fermand JP, Bridoux F, Kyle RA, et al. How I treat monoclonal gammopathy of renal significance (MGRS). Blood 2013;122:3583–3590.
- Zheng F, Zhao S, Li X. [The clinical and biochemical manifestations of Fanconi syndrome: a report of 42 cases]. Zhonghua Nei Ke Za Zhi 2000;39:735–738.
- International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749–757.
- Sirota JH, Hamerman D. Renal function studies in a adult subject with the Fanconi syndrome. Am J Med 1954;16:138–152.
- Ma CX, Lacy MQ, Rompala JF, et al. Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. Blood 2004;104:40–42.
- Messiaen T, Deret S, Mougenot B, et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore) 2000;79: 135–154.
- Lajoie G, Leung R, Bargman JM. Clinical, biochemical, and pathological features in a patient with plasma cell dyscrasia and Fanconi syndrome. Ultrastruct Pathol 2000;24:221–226.
- Sirac C, Bridoux F, Carrion C, et al. Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood 2006;108:536–543.
- Deret S, Denoroy L, Lamarine M, et al. Kappa light chain-associated Fanconi's syndrome: molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals. Protein Eng 1999;12:363–369.
- Decourt C, Bridoux F, Touchard G, et al. A monoclonal V kappa l light chain responsible for incomplete proximal tubulopathy. Am J Kidney Dis 2003;41:497–504.
- Bridoux F, Sirac C, Hugue V, et al. Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia. Am J Kidney Dis 2005;45:749–757.
- Guan S, el-Dahr S, Dipp S, et al. Inhibition of Na-K-ATPase activity and gene expression by a myeloma light chain in proximal tubule cells. J Investig Med 1999;47:496–501.
- El Hamel C, Aldigier JC, Oblet C, et al. Specific impairment of proximal tubular cell proliferation by a monoclonal kappa light chain responsible for Fanconi syndrome. Nephrol Dial Transplant 2012;27:4368–4377.
- Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009;113:5412–5417.
- Nishida Y, Iwama K, Yamakura M, et al. Renal Fanconi syndrome as a cause of chronic kidney disease in patients with monoclonal gammopathy of undetermined significance: partially reversed renal function by high-dose dexamethasone with bortezomib. Leuk Lymphoma 2012;53:1804–1806.
- Dash T, Parker MG, Lafayette RA. Profound hypophosphatemia and isolated hyperphosphaturia in two cases of multiple myeloma. Am J Kidney Dis 1997;29:445–448.
- Narvaez J, Domingo-Domenech E, Narvaez JA, et al. Acquired hypophosphatemic osteomalacia associated with multiple myeloma. Joint Bone Spine 2005;72:424–426.
- Bhutani M, Klein MJ, Glezerman I, et al. Osteomalacia due to adult Fanconi syndrome in multiple myeloma. Leuk Lymphoma 2011;52:536–538.
- Uchida S, Matsuda O, Yokota T, et al. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma. Nephron 1990;55: 332–335.